NLRP3/AIM2-IN-3
NLRP3/AIM2-IN-3 (compound 59) is a potent inhibitor with differential species specific effects against NLRP3 and AIM2 inflammasome-dependent pyroptosis. NLRP3/AIM2-IN-3 shows inhibitory efficacy against pyroptosis in THP-1 macrophages stimulated with LPS/nigericin, with an IC50 of 0.077 ± 0.008 μM. NLRP3/AIM2-IN-3 disturbs the interaction of NLRP3 or AIM2 with the adaptor protein ASC and inhibited ASC oligomerization[1].
Product Specifications
CAS Number
[1787787-60-3]
UNSPSC
12352005
Target
AIM2; NOD-like Receptor (NLR) ; Pyroptosis
Type
Reference compound
Related Pathways
Apoptosis; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/nlrp3-aim2-in-3.html
Purity
98.23
Solubility
DMSO : 250 mg/mL (ultrasonic) |Methanol : 50 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=CC(O)=C1)CC2=CC3=C(C=C2)C=CN3
Molecular Formula
C16H14N2O2
Molecular Weight
266.29
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
NLRP3
Available Sizes
Explore Other Products
Browse additional items from our catalog
Rac atomoxetine hydrochloride discontinued. See 002930
Rac atomoxetine hydrochloride discontinued. See 002930
Rac atomoxetine hydrochloride discontinued. See 002930
Rac atomoxetine hydrochloride discontinued. See 002930